7th annual ADMET conference, 9th & 10th July 2012 in London

March 23, 2012 - PRLog -- ADMET studies perform a vital role in the drug discovery process. This conference will address the barriers that are currently faced by the PK/PD community and also how recent discoveries have improved the understanding of the mechanisms involved in ADME-Tox. It will also address the new technologies and techniques being developed to overcome the classic physiological barriers to drug bioavailability.

Attendees will hear presentations from senior experts in the field on the current issues as well as case studies from recent drug development programmes.

Reason why you should attend:
• Presentations from a verity of top Pharma companies discussing their approaches to DMPK and Tox studies.

• Half day session focusing on the latest strategies and recommendations for transporter studies and evaluation of potential DDIs

• Case study of the application of drug transporter studies in recent development by Galapagos

• Discussion of the challenges faced by drugs targets to the CNS and how to optimise your drug for CNS penetration.

• Overviews of the latest developments in In-Silico and In-Vitro techniques for predicting the success of new drug candidates

Visit our website here: www.smi-online.co.uk/2012admet17.asp

**Book by 5th April 2012 and Save £300**

Alternatively Contact Lola Ameh on telephone +44 (0) 20 7827 6722
or email on lameh@smi-online.co.uk